newsfilter
← Latest News
Business Wire·

Oragenics to Participate at the World Vaccine Congress Washington 2022

Company to showcase NT-CoV2-1, a patient-friendly Covid vaccine candidate Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company"), a biotech company dedicated to fighting infectious diseases including coronavirus, today announced that Kimberly Mur